Research ArticleOriginal Article
Open Access

Exploring the quality of life and comorbidity impact among patients with systemic lupus erythematosus in Saudi Arabia

Roaa A. Aljohani, Ghada A. Aljanobi, Khaled Alderaan and Mohammed A. Omair
Saudi Medical Journal October 2024, 45 (10) 1071-1079; DOI: https://doi.org/10.15537/smj.2024.45.10.20240432

References

  1. 1.↵
    1. Hasan B,
    2. Fike A,
    3. Hasni S
    . Health disparities in systemic lupus erythematosus-a narrative review. Clin Rheumatol 2022; 41: 3299-3311.
    OpenUrl
  2. 2.↵
    1. Kumar R,
    2. Kumar A,
    3. Saroj U,
    4. Kumar M,
    5. Singh SK,
    6. Kumar A, et al.
    A cross-sectional study of clinical and laboratory characteristics of systemic lupus erythematosus in tribal region of Jharkhand at RIMS, Ranchi. J Family Med Prim Care 2022; 11: 7836-7841.
    OpenUrl
  3. 3.↵
    1. Almaghlouth IA,
    2. Hassen LM,
    3. Alahmari HS,
    4. Bedaiwi A,
    5. Albarrak R,
    6. Daghestani M, et al.
    National systemic lupus erythematosus prospective cohort in Saudi Arabia: a study protocol. Medicine (Baltimore) 2021; 100: e26704.
    OpenUrl
  4. 4.↵
    1. Toloza SM,
    2. Sequeira W,
    3. Jolly M
    . Treatment of lupus: impact on quality of life. Curr Rheumatol Rep 2011; 13: 324-337.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Olesińska M,
    2. Saletra A
    . Quality of life in systemic lupus erythematosus and its measurement. Reumatologia 2018; 56: 45-54.
    OpenUrlPubMed
  6. 6.↵
    1. Gergianaki I,
    2. Garantziotis P,
    3. Adamichou C,
    4. Saridakis I,
    5. Spyrou G,
    6. Sidiropoulos P, et al.
    High comorbidity burden in patients with SLE: data from the community-based lupus registry of Crete. J Clin Med 2021; 10: 998.
    OpenUrl
  7. 7.↵
    1. González LA,
    2. Alarcón GS
    . The evolving concept of SLE comorbidities. Expert Rev Clin Immunol 2017; 13: 753-768.
    OpenUrlPubMed
  8. 8.↵
    1. Parker B,
    2. Urowitz MB,
    3. Gladman DD,
    4. Lunt M,
    5. Bae SC,
    6. Sanchez-Guerrero J, et al.
    Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis 2013; 72: 1308-1314.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Jönsen A,
    2. Clarke AE,
    3. Joseph L,
    4. Belisle P,
    5. Bernatsky S,
    6. Nived O, et al.
    Association of the Charlson comorbidity index with mortality in systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011; 63: 1233-1237.
    OpenUrl
  10. 10.↵
    1. Cao L,
    2. Tong H,
    3. Xu G,
    4. Liu P,
    5. Meng H,
    6. Wang J, et al.
    Systemic lupus erythematous and malignancy risk: a meta-analysis. PLoS One 2015; 10: e0122964.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Córdoba-Sánchez V,
    2. Limonero-García JT
    . [Coping and quality of life in patients with systemic lupus erythematosus: a review]. Pensando Psicol 2015; 11: 129-139. [In Spanish].
    OpenUrl
  12. 12.↵
    1. Kiani AN,
    2. Petri M
    . Quality-of-life measurements versus disease activity in systemic lupus erythematosus. Curr Rheumatol Rep 2010; 12: 250-258.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Strand V,
    2. Gladman D,
    3. Isenberg D,
    4. Petri M,
    5. Smolen J,
    6. Tugwell P
    . Endpoints: consensus recommendations from OMERACT IV. Outcome measures in rheumatology. Lupus 2000; 9: 322-327.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Tugwell P,
    2. Chambers L,
    3. Torrance G,
    4. Reynolds D,
    5. Wolfson M,
    6. Bennett K, et al.
    The population health impact of arthritis. POHEM Workshop Group. J Rheumatol 1993; 20: 1048-1051.
    OpenUrlPubMedWeb of Science
  15. 15.↵
    1. Mosca M,
    2. Tani C,
    3. Aringer M,
    4. Bombardieri S,
    5. Boumpas D,
    6. Brey R, et al.
    European league against rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 2010; 69: 1269-1274.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Jolly M,
    2. Pickard AS,
    3. Block JA,
    4. Kumar RB,
    5. Mikolaitis RA,
    6. Wilke CT, et al.
    Disease-specific patient reported outcome tools for systemic lupus erythematosus. Semin Arthritis Rheum 2012; 42: 56-65.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Giangreco D,
    2. Devilliers H,
    3. Annapureddy N,
    4. Block JA,
    5. Jolly M
    . THU0440 Lupuspro is responsive to changes in disease activity over time. Ann Rheum Dis 2014; 73: 335.
    OpenUrl
  18. 18.↵
    1. Azizoddin DR,
    2. Weinberg S,
    3. Gandhi N,
    4. Arora S,
    5. Block JA,
    6. Sequeira W, et al.
    Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus. Lupus 2018; 27: 728-737.
    OpenUrl
  19. 19.↵
    1. Hochberg MC
    . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Cochran WG
    . Sampling techniques, 3rd edition. [Updated 1991; 2023 Jan 7]. Available from: https://www.wiley.com/en-us/Sampling+Techniques%2C+3rd+Edition-p-9780471162407
  21. 21.↵
    1. Elkaraly NE,
    2. Nasef SI,
    3. Omar AS,
    4. Fouad AM,
    5. Jolly M,
    6. Mohamed AE
    . The Arabic LupusPRO: a cross-cultural validation of a disease-specific patient-reported outcome tool for quality of life in lupus patients. Lupus 2020; 29: 1727-1735.
    OpenUrl
  22. 22.↵
    1. Alarcón GS,
    2. McGwin G Jr.,
    3. Uribe A,
    4. Friedman AW,
    5. Roseman JM,
    6. Fessler BJ, et al.
    Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum 2004; 51: 465-474.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.
    1. Lash AA
    . Quality of life in systemic lupus erythematosus. Appl Nurs Res 1998; 11: 130-137.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Thibault T,
    2. Rajillah A,
    3. Bourredjem A,
    4. Corneloup M,
    5. Maurier F,
    6. Wahl D, et al.
    Health-related quality of life, remission and low lupus disease activity state in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2024; 63: 1447-1455.
    OpenUrl
  25. 25.↵
    1. Hanly JG
    . Disease activity, cumulative damage and quality of life in systematic lupus erythematosus: results of a cross-sectional study. Lupus 1997; 6: 243-247.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Stoll T,
    2. Gordon C,
    3. Seifert B,
    4. Richardson K,
    5. Malik J,
    6. Bacon PA, et al.
    Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997; 24: 1608-1614.
    OpenUrlPubMedWeb of Science
  27. 27.↵
    1. Rinaldi S,
    2. Doria A,
    3. Salaffi F,
    4. Ermani M,
    5. Iaccarino L,
    6. Ghirardello A, et al.
    Health-related quality of life in Italian patients with systemic lupus erythematosus. I. relationship between physical and mental dimension and impact of age. Rheumatology (Oxford) 2004; 43: 1574-1579.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Gladman DD,
    2. Urowitz MB,
    3. Ong A,
    4. Gough J,
    5. MacKinnon A
    . A comparison of 5 health status instruments in patients with systemic lupus erythematosus (SLE). Lupus 1996; 5: 190-195.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. McElhone K,
    2. Abbott J,
    3. Teh LS
    . A review of health related quality of life in systemic lupus erythematosus. Lupus 2006; 15: 633-643.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Jolly M,
    2. Sequeira W,
    3. Block JA,
    4. Toloza S,
    5. Bertoli A,
    6. Blazevic I, et al.
    Gender differences in quality of life in patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2019; 71: 1647-1652.
    OpenUrl
  31. 31.↵
    1. Zhang L,
    2. Fu T,
    3. Yin R,
    4. Zhang Q,
    5. Shen B
    . Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry 2017; 17: 70.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. McElhone K,
    2. Abbott J,
    3. Gray J,
    4. Williams A,
    5. Teh LS
    . Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study. Lupus 2010; 19: 1640-1647.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Beckerman NL,
    2. Auerbach C,
    3. Blanco I
    . Psychosocial dimensions of SLE: implications for the health care team. J Multidiscip Healthc 2011; 4: 63-72.
    OpenUrlPubMed
  34. 34.↵
    1. Sutanto B,
    2. Singh-Grewal D,
    3. McNeil HP,
    4. O’Neill S,
    5. Craig JC,
    6. Jones J, et al.
    Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies. Arthritis Care Res (Hoboken) 2013; 65: 1752-1765.
    OpenUrl
  35. 35.↵
    1. Bruce IN,
    2. Mak VC,
    3. Hallett DC,
    4. Gladman DD,
    5. Urowitz MB
    . Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis 1999; 58: 379-381.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Lai JS,
    2. Beaumont JL,
    3. Ogale S,
    4. Brunetta P,
    5. Cella D
    . Validation of the functional assessment of chronic illness therapy-fatigue scale in patients with moderately to severely active systemic lupus erythematosus, participating in a clinical trial. J Rheumatol 2011; 38: 672-679.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Petri M,
    2. Kawata AK,
    3. Fernandes AW,
    4. Gajria K,
    5. Greth W,
    6. Hareendran A, et al.
    Impaired health status and the effect of pain and fatigue on functioning in clinical trial patients with systemic lupus erythematosus. J Rheumatol 2013; 40: 1865-1874.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Robinson D Jr.,
    2. Aguilar D,
    3. Schoenwetter M,
    4. Dubois R,
    5. Russak S,
    6. Ramsey-Goldman R, et al.
    Impact of systemic lupus erythematosus on health, family, and work: the patient perspective. Arthritis Care Res (Hoboken) 2010; 62: 266-273.
    OpenUrl
  39. 39.↵
    1. Blomjous BS,
    2. Gajadin GRS,
    3. Voskuyl AE,
    4. Falzon L,
    5. Hoving JL,
    6. Bultink IEM, et al.
    Work participation in patients with systematic lupus erythematosus: a systematic review. Rheumatology (Oxford) 2022; 61: 2740-2754.
    OpenUrl
  40. 40.↵
    1. Rizk A,
    2. Gheita TA,
    3. Nassef S,
    4. Abdallah A
    . The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis. Int J Rheum Dis 2012; 15: 261-267.
    OpenUrlCrossRefPubMed
  41. 41.
    1. Baker K,
    2. Pope J,
    3. Fortin P,
    4. Silverman E,
    5. Peschken C
    . Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors. Lupus 2009; 18: 1281-1288.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.
    1. Kim SK,
    2. Choe JY,
    3. Lee SS
    . Charlson comorbidity index is related to organ damage in systemic lupus erythematosus: data from KORean lupus Network (KORNET) Registry. J Rheumatol 2017; 44: 452-458.
    OpenUrlAbstract/FREE Full Text
  43. 43.↵
    1. Han GM,
    2. Han XF
    . Comorbid conditions are associated with emergency department visits, hospitalizations, and medical charges of patients with systemic lupus erythematosus. J Clin Rheumatol 2017; 23: 19-25.
    OpenUrl
  44. 44.↵
    1. Rees F,
    2. Doherty M,
    3. Grainge M,
    4. Lanyon P,
    5. Davenport G,
    6. Zhang W
    . Burden of comorbidity in systemic lupus erythematosus in the UK, 1999-2012. Arthritis Care Res (Hoboken) 2016; 68: 819-827.
    OpenUrl
  45. 45.↵
    1. Kuo CF,
    2. Chou IJ,
    3. Rees F,
    4. Grainge MJ,
    5. Lanyon P,
    6. Davenport G, et al.
    Temporal relationships between systemic lupus erythematosus and comorbidities. Rheumatology (Oxford) 2019; 58: 840-848.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords